New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations and those who did not experience exacerbations. Higher health care costs ...

Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...

A COPD exacerbation can feel scary in the moment, and it’s natural to experience lingering worry about another flare-up. Having a set of go-to tips can help you mentally cope during — and recover from ...

Comorbidities and older age increase the risk of severe COVID-19 in MG patients, but not susceptibility to infection. MG treatments, including corticosteroids and immunosuppressants, do not heighten ...

Initiation of GLP-1 receptor agonists was linked to fewer asthma exacerbations across overweight, obese, and morbidly obese patient cohorts.

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...